Transcriptome association analysis identifies miR-375 as a major determinant of variable acetaminophen glucuronidation by human liver
- 1 October 2016
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 117, 78-87
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Institute of General Medical Sciences (NIH-R01-GM102130)
- National Institute of Diabetes and Digestive and Kidney Diseases (N01-DK-7-0004)
This publication has 37 references indexed in Scilit:
- Regulation of PP2Cm expression by miRNA-204/211 and miRNA-22 in mouse and human cellsActa Pharmacologica Sinica, 2015
- Bioinformatic tools for microRNA dissectionNucleic Acids Research, 2015
- Regulation of UDP-Glucuronosyltransferase 1A1 Expression and Activity by MicroRNA 491-3pThe Journal of Pharmacology and Experimental Therapeutics, 2014
- MicroRNA expression is differentially altered by xenobiotic drugs in different human cell linesBiopharmaceutics & Drug Disposition, 2011
- UDP-glucuronosyltransferases (UGTs): from purification of Ah-receptor–inducible UGT1A6 to coordinate regulation of subsets of CYPs, UGTs, and ABC transporters by nuclear receptorsDrug Metabolism Reviews, 2009
- miR-375 maintains normal pancreatic α- and β-cell massProceedings of the National Academy of Sciences, 2009
- Post-transcriptional Regulation of Human Pregnane X Receptor by Micro-RNA Affects the Expression of Cytochrome P450 3A4Journal of Biological Chemistry, 2008
- The microRNA.org resource: targets and expressionNucleic Acids Research, 2007
- Validation of Serotonin (5-Hydroxtryptamine) as an in Vitro Substrate Probe for Human UDP-Glucuronosyltransferase (UGT) 1A6Drug Metabolism and Disposition, 2003
- Deficiency in bilirubin UDP-glucuronyl transferase as a genetic determinant of acetaminophen toxicity.The Journal of Pharmacology and Experimental Therapeutics, 1988